期刊文献+

GC-MS法分析利奈唑胺中的两种基因毒性杂质 被引量:3

Determination of acetamide residue in Linezolid by GC-MS
原文传递
导出
摘要 目的采用气相色谱质谱联用法(GC-MS)测定利奈唑胺中的两种基因毒性杂质S-环氧氯丙烷(ECH)与(S)-N-[2-(乙酰氧基-3-氯丙基)]乙酰胺(ACPA)的残留量。方法采用DB-5MS色谱柱(30 m×0.25 mm,0.25μm),柱温采用程序升温,采用单级四级杆质谱检测器,载气以线速度控制模式,初始流量为1.3 mL·min-1,采集模式SIM,不分流进样。结果 ECH、ACPA的线性范围分别为5.119~341.236 ng·mL-1(r=0.9995)、5.308~353.864 ng·mL-1(r=0.9999),平均回收率分别为91.2%、87.5%。结论所用方法操作简便、结果准确、灵敏度及重复性好,可用于利奈唑胺中两种基因毒性杂质的质量控制。 OBJECTIVE To establish a GC-MS method for the determination of the genotoxic impurities of(S)-(+)-epichlorohydrin(ECH) and(S)-N-[2-(Acetyloxy)-3-chloropropyl]acetamide(ACPA) in Linezolid.METHODS DB-5 MS column(30 m×0.25 mm,0.25 μm)and temperature programming were adopted for the determination with MS detector.Carrier gas was helium and the initial flow rate was 1.3 mL·min-1.Acquisition mode was SIM with splitless injection.RESULTS The linear range of ECH was obtained between 5.119-341.236 ng·mL-1(r=0.9995);the linear range of ACPA was obtained between 5.308-353.864 ng·mL-1(r=0.9999).The average recovery of ECH and ACPA were 91.2% and 87.5%,respectively.CONCLUSION The method is simple,accurate,reliable and reproducible.The method can be applied to the genotoxic impurity ECH and ACPA determination in Linezolid.
作者 苟琰 耿昭 刘爱 周娟 袁军 李敏 GOU Yan;GENG Zhao;LIU Ai;ZHOU Juan;YUAN Jun;LI Min(Sichuan Provincial Institute for Food and Drug Control,Chengdu,Sichuan,611731 P.R.China;State Key Laboratory Breeding Base of Systematic Research,Development and Utilization of Chinese Medicine Resources,Chengdu University of Traditional Chinese Medicine,Chengdu,Sichuan,611173 P.R.China;Chengdu Zihao Pharmaceutical Co.,Ltd.,Chengdu,Sichuan,620041 P.R.China)
出处 《华西药学杂志》 CAS CSCD 2020年第2期205-207,共3页 West China Journal of Pharmaceutical Sciences
关键词 利奈唑胺 气相色谱质谱联用法 基因毒性杂质 S-环氧氯丙烷 (S)-N-[2-(乙酰氧基-3-氯丙基)]乙酰胺 残留量 质量控制 Linezolid GC-MS Genotoxic impurities (S)-(+)-epichlorohydrin (S)-N-[2-(Acetyloxy)-3-chloropropyl] Residue Quality control
  • 相关文献

参考文献5

二级参考文献40

  • 1唐励文,陈小辉,刘丽仪,陈锋,华勃.饮用水中环氧氯丙烷分析方法的研究[J].分析试验室,2008,27(S1):145-146. 被引量:16
  • 2任国凤,戴传波,张思科.二乙二醇二缩水甘油醚合成工艺研究[J].化学工业与工程技术,2004,25(5):18-19. 被引量:7
  • 3余德胜,王志谦,熊莺,赵燕芳,宫平.利奈唑酮合成新工艺[J].中国药物化学杂志,2005,15(2):89-90. 被引量:8
  • 4徐宇红,路秀玲,郑春杨,谭天伟,苏志国.乙二醇二缩水甘油醚交联血红蛋白的反应优化[J].高校化学工程学报,2006,20(3):401-406. 被引量:5
  • 5Manzano V, Ruiz P, Torres M, et al. Severe pneumonia by ac- iclovir-resistant varieella-zoster virus during etanercept thera- py[J]. Rheumatology, 2010,49(9) : 1791-1793.
  • 6Kalil AC,Myrthy MH, Hermsen ED,et al. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a sys- tematic review and meta-analysis[J]. Critical Care Medicine, 2010,38( 9), 1802-1808.
  • 7Wolff M,Mourvillier B. Linezolid for the treatment of noso- comia[ pneumonia due to methicillin-resistant Staphylococcus aureus[J]. Clinical infectious diseases,2012,55(1) :160-161.
  • 8Doeobo-P6rez F, L6pez-Roias R, Dominguez-Herrera J, er al. Efficacy of linezolid versus a pharmacodynamieally optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus [J ]. Journa[ of Antimicrohial Chemotherapy, 2012, 67 ( 8 ) : 1961:- 1967.
  • 9H an S H,Chin B S, Lee H S,et al. Vancomycin-resistant en- terococci hactercmia: risk factors for mortality and influence of antimicrohial therapy on clinical outcome [J]. Journal of Infection, 2009,58(3) : 182-190.
  • 10Khanafer N, Sicot N, Vanhems P, et al. Severe leukopenia in Staphylococcus aureus necrotizing, comrnunity-acquired pneumonia: risk factors and impact on survival[J]. BMC in- fectious diseases,2013,13(1) : 1-8.

共引文献24

同被引文献62

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部